LUZP1 and neoplasm: The heterozygous loss of LUZP1 observed in tumor samples could be the consequence of the balance between the advantage of decreasing LUZP1 levels enough to promote invasion and the counterselection of complete loss to avoid genomic instability or cell division defects leading to apoptosis.